
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
New Orleans - Pregnancy can affect the skin in a variety of ways, leading to physiologic changes, alterations in the course of many skin diseases and tumors, as well as the development